Royalty Pharma's Q4 results show portfolio receipts of $742 million and operating cash flow of $678 million. Read why RPRX ...

We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Pablo Legorreta, CEO, highlighted strong 2024 performance, with Portfolio Receipts reaching $2.8 billion, at the high end of guidance and representing 13% growth in Royalty Receipts. He noted this ...

Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.

PC hardware is nice, but it’s not much use without innovative software. I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo ...

Jackson Mahomes’ appearance at Super Bowl 2025 to watch his brother — and Chiefs star quarterback — Patrick Mahomes included a stop for a photo with President Donald Trump, according to a ...

Searchlight Pictures /Courtesy Everett Collection ©Searchlight Pictures/Courtesy Everett Collection Best Picture commentary (Updated Feb. 11, 2025): Sean Baker’s $6 million Palme d’Or winner ...

Niday Picture Library / Alamy Stock Photo 24.Here's Hannes de Jong, the 1970 Pole Sitting World Champion, well, sitting on a pole: Yes, the World Pole Sitting Championship was a real thing.

The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...

Best Picture commentary (Updated Feb. 5, 2025): This weekend, three major guilds — the Critics Choice Awards (whose final voting closed Jan. 10, before the whole “Emilia Pérez” drama), the ...